ADMA Biologics(ADMA)
$13.19+0.52 (+4.10%)
ADMA
ADMA Biologics Revenue
$13.19
At close:+0.52 (+4.10%)
Want to see ADMA full AI Analyst Report?
ADMA Biologics (ADMA) Revenue
3,061 Followers
ADMA Biologics Revenue
ADMA Biologics had a revenue of 141.10M in the quarter ending Sep 30, 2026, with 13.43%. This bring the company's revenue in the last twelve months to 519.15M, Increased 1.34%. In the fiscal year ending Dec 31, 2025, ADMA Biologics had annual revenue of 510.17M with 19.63% growth.
- Revenue (ttm)
- 519.15M
- Revenue Growth
- 6.26%
- P/S Ratio
- 5.51
- Revenue/Employee
- $792,194
- Employees
- 644
- Market Cap
- $2.81B
Revenue Chart
ADMA Biologics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 510.17M | 83.72M | 19.63% |
| Dec 31, 2024 | 426.45M | 168.24M | 65.15% |
| Dec 31, 2023 | 258.21M | 104.14M | 67.59% |
| Dec 31, 2022 | 154.08M | 73.14M | 90.36% |
| Dec 31, 2021 | 80.94M | 38.72M | 91.72% |
| Dec 31, 2020 | 42.22M | 12.87M | 43.85% |
| Dec 31, 2019 | 29.35M | 12.36M | 72.79% |
| Dec 31, 2018 | 16.99M | -5.78M | -25.37% |
| Dec 31, 2017 | 22.76M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.